Literature DB >> 31097787

STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia.

Qinjie Weng1,2, Mengting Zhao1, Jiahuan Zheng1, Lijun Yang1, Zijie Xu1, Zhikang Zhang1, Jincheng Wang1, Jiajia Wang1, Bo Yang1, Q Richard Lu3, Meidan Ying4, Qiaojun He5,6.   

Abstract

Insufficient pancreatic β-cell mass or insulin-producing β-cells are implicated in all forms of diabetes mellitus. However, the molecular mechanisms underlying β-cell destruction are complex and not fully defined. Here we observed that activation of STAT3 is intensely and specifically inhibited in β-cells under hyperglycemic conditions. By knocking out STAT3 specifically in mouse β-cells, we found that the loss of STAT3 sensitized mice to three low doses of STZ stimulation resulting in hyperglycemia. Mechanistically, accumulating PTEN, induced by STAT3 deficiency, directly represses phosphorylation of AKT, which negatively modulates transcription factor activation, dysregulates β-cell function, positively promotes apoptotic signaling, and finally induces β-cell apoptosis. Notably, the defective secretion of insulin and β-cells apoptosis was completely rescued by PTEN ablation in STAT3-null islets or PTEN inhibitor bpv(phen) treatment. Thus our data suggest that STAT3 is a vital modulator of β-cell survival and function, highlighting a critical role for STAT3 in the negative regulation of PTEN-AKT signaling pathway associated with β-cell dysfunction and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31097787      PMCID: PMC7205876          DOI: 10.1038/s41418-019-0344-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  72 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

2.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.

Authors:  S Lenzen; J Drinkgern; M Tiedge
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 3.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 4.  Life and death of β cells in Type 1 diabetes: A comprehensive review.

Authors:  Nicholas S Wilcox; Jinxiu Rui; Matthias Hebrok; Kevan C Herold
Journal:  J Autoimmun       Date:  2016-03-24       Impact factor: 7.094

Review 5.  Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Authors:  Hua Yu; Marcin Kortylewski; Drew Pardoll
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

Review 6.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 7.  Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.

Authors:  R Paul Robertson; Jamie Harmon; Phuong Oanh T Tran; Vincent Poitout
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

8.  Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes.

Authors:  Benbo Song; Donalyn Scheuner; David Ron; Subramaniam Pennathur; Randal J Kaufman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  A New Drug Target for Type 2 Diabetes.

Authors:  Lukas K J Stadler; I Sadaf Farooqi
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

View more
  7 in total

1.  MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT.

Authors:  Jun Meng; Can Xu
Journal:  J Cell Mol Med       Date:  2022-02-13       Impact factor: 5.310

2.  Abnormal expression of TRIAP1 and its role in gestational diabetes mellitus-related pancreatic β cells.

Authors:  Linxia Li; Kaihan Yang; Fang Ye; Yi Xu; Lili Cao; Jia Sheng
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

3.  Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.

Authors:  Kazunori Tokuda; Tetsuya Ikemoto; Shoko Yamashita; Katsuki Miyazaki; Shohei Okikawa; Shinichiro Yamada; Yu Saito; Yuji Morine; Mitsuo Shimada
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

4.  MicroRNA-181a-5p Promotes Osteosarcoma Progression via PTEN/AKT Pathway.

Authors:  Chen Sun; Chi Chen; Zhen Chen; Jun Guo; Zhi-Hong Yu; Wei Qian; Fen Ai; Liang Xiao; Xiao Guo
Journal:  Anal Cell Pathol (Amst)       Date:  2022-03-08       Impact factor: 2.916

5.  MicroRNA-4516 in Urinary Exosomes as a Biomarker of Premature Ovarian Insufficiency.

Authors:  Zobia Umair; Mi-Ock Baek; Jisue Song; Seona An; Seung Joo Chon; Mee-Sup Yoon
Journal:  Cells       Date:  2022-09-07       Impact factor: 7.666

6.  MicroRNA-325-3p Facilitates Immune Escape of Mycobacterium tuberculosis through Targeting LNX1 via NEK6 Accumulation to Promote Anti-Apoptotic STAT3 Signaling.

Authors:  Beibei Fu; Weiwei Xue; Haiwei Zhang; Rui Zhang; Kelly Feldman; Qingting Zhao; Shanfu Zhang; Lei Shi; Krishna Chaitanya Pavani; Weiqi Nian; Xiaoyuan Lin; Haibo Wu
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867

7.  Bioinformatic Reconstruction and Analysis of Gene Networks Related to Glucose Variability in Diabetes and Its Complications.

Authors:  Olga V Saik; Vadim V Klimontov
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.